Solanbridge Group Inc. logo

Solanbridge Group Inc. (SLNX)

Market Closed
11 Aug, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
476K Market Cap
- P/E Ratio
- Div Yield
1.33M Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track SLNX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SLNX closed yesterday higher at $0, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, SLNX stock gained 400%.
SLNX is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

SLNX Chart

Solanbridge Group Inc. (SLNX) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Solanbridge Group Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is SLNX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 476K.

Has Solanbridge Group Inc. ever had a stock split?

No, there has never been a stock split.

Solanbridge Group Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
David J. Cutler CEO
OTC PINK Exchange
83412T104 CUSIP
US Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Solanbridge Group, Inc. is a company founded in 2000, with its headquarters located in The Woodlands, Texas. It operates in the cannabis industry, focusing on the production and sale of medical marijuana and CBD-infused products. The company's operations span across North America, with specific attention to Nova Scotia, Canada for medical marijuana, and Nevada, California, and Colorado for its CBD product lines. Solanbridge Group, Inc. aims to leverage the growing acceptance and legalization of cannabis products for medicinal and recreational purposes to expand its market reach and diversify its product offerings.

Products and Services

  • Medical Marijuana in Nova Scotia, Canada:

    Solanbridge Group, Inc. plans to produce and distribute medical marijuana in Nova Scotia, Canada. This effort targets patients who are prescribed cannabis for various therapeutic purposes, aligning with Canadian regulations on medical cannabis. By entering the Canadian medical marijuana market, the company aims to meet the growing demand for quality-controlled and legally compliant cannabis products for medicinal use.

  • CBD-infused Products in Nevada, California, and Colorado:

    The company also focuses on the development, production, and sale of CBD-infused products in the U.S. states of Nevada, California, and Colorado. These products range from edibles and topicals to tinctures and capsules that are infused with Cannabidiol (CBD), a non-psychoactive compound found in cannabis. Targeting wellness-conscious consumers, Solanbridge's CBD products are designed to offer various health benefits, such as pain relief, anxiety reduction, and improved sleep, without the high associated with THC.

Contact Information

Address: PO Box 147199
Phone: 832-225-1372